Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CETRO Trial: Early vs Late Fixed Start GnRH Antagonist in IVF/ICSI
NCT00866034Phase 4Terminated
- Start
- Feb 2009
- Primary completion
- Oct 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cetrorelix in infertility (2 arms). Primary endpoint: Live Birth Rate Per Started Cycle at 2 years. Started Feb 2009; status: terminated.
02
Drugs
cetrorelix
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00866034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866034.